Published in N Y State J Med on November 01, 1972
New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol (1972) 4.86
A tabulated summary of the FDG PET literature. J Nucl Med (2001) 4.37
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med (2000) 2.10
Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes. Infect Immun (1999) 1.83
High-pressure liquid chromatographic-fluorometric detection of adenosine and adenine nucleotides: application to endogenous content and electrically induced release of adenyl purines in guinea pig vas deferens. Anal Biochem (1984) 1.29
Withdrawal of propranolol and myocardial infarction. Lancet (1973) 1.23
Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am Heart J (1974) 1.22
Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg (2001) 1.19
Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg (2000) 1.13
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. N Engl J Med (1975) 1.06
Pulmonary venous flow pattern--its relationship to cardiac dynamics. A pulsed Doppler echocardiographic study. Circulation (1985) 1.04
Myocardial infarction after propranolol withdrawal. Am Heart J (1974) 1.04
Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. J Viral Hepat (2010) 1.01
Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro. Clin Exp Immunol (2009) 0.97
Sleep regimen for myocardial infarction. Lancet (1968) 0.96
Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines. J Pharmacol Exp Ther (1988) 0.95
Some aspects of the cardiac actions of reserpine and pronethalol. Fed Proc (1966) 0.92
The cimetidine-lidocaine interaction. Ann Intern Med (1983) 0.92
Factors influencing the release of purines and norepinephrine in the rabbit portal vein. Blood Vessels (1982) 0.90
Haemodynamic effects of isoprenaline in acute myocardial infarction. Br Heart J (1972) 0.90
Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies. Q J Nucl Med (2000) 0.88
Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: relationship to TH1 and TH2 cytokine profile. Arch Neurol (2000) 0.87
Neuroexcitatory effects of digitalis and their role in the development of cardiac arrhythmias. J Pharmacol Exp Ther (1972) 0.87
Hemodynamic effects of isoproterenol in cardiac surgery. J Thorac Cardiovasc Surg (1971) 0.87
COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma. J Clin Oncol (1988) 0.86
Bifascicular block: a clinical and electrophysiologic study. Am Heart J (1973) 0.86
The effect of spinal section on ventricular rhythm disorders induced by ouabain. Arch Int Pharmacodyn Ther (1967) 0.86
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B. Aliment Pharmacol Ther (2009) 0.86
Some factors affecting ouabain-induced ventricular arrhythmia in the reserpine-treated cat. Br J Pharmacol Chemother (1967) 0.84
Alteration of the effects and distribution of ouabain by spinal cord transection in the cat. J Pharmacol Exp Ther (1973) 0.84
Some aspects of the anti-arrhythmic activity of reserpine. Br J Pharmacol Chemother (1966) 0.83
The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther (1974) 0.83
Pulmonary edema associated with pulmonary embolism: a clinicopathological study. Angiology (1971) 0.82
The effect of guanethidine on ouabain-induced ventricular arrhythmia in the cat. Arch Int Pharmacodyn Ther (1968) 0.82
Existing and new criteria for bioequivalence evaluation of new controlled release (CR) products of carbamazepine. Epilepsy Res (1998) 0.81
The influence of prostaglandins E1 and E2 on ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther (1977) 0.81
Strongyloides stercoralis autoinfection. JAMA (1971) 0.81
Specificity of capsaicin treatment in the cerebral vasculature. Brain Res (1984) 0.81
A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine. Clin Pharmacol Ther (1999) 0.80
Ouabain cardiotoxicity, a reassessment of methodology. Arch Int Pharmacodyn Ther (1976) 0.80
Antihydrogen production within a Penning-Ioffe trap. Phys Rev Lett (2008) 0.80
Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine. Epilepsia (1998) 0.80
Autonomic nervous system and control of cardiac rhythm. Nature (1967) 0.80
Clinical use of digitalis materials. J Clin Pharmacol (1985) 0.80
Echocardiographic findings in a patient with Candida endocarditis of the aortic valve. Chest (1976) 0.80
Advances in chemotherapy for large cell lymphoma. Semin Hematol (1987) 0.79
Transient functional asplenism in sickle cell-C disease. Am J Med (1973) 0.79
The capacity of different digitalis materials to induce ventricular rhythm disturbances in the reserpine-pretreated cat. J Pharmacol Exp Ther (1967) 0.79
Role of the nervous system in the genesis of cardiac rhythm disorders. Am J Cardiol (1976) 0.79
Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther (1980) 0.79
Economic evaluation studies in nuclear medicine: a methodological review of the literature. Q J Nucl Med (2000) 0.78
Prejunctional alpha 2-adrenoceptors modulate stimulation-evoked norepinephrine release in rabbit lateral saphenous vein. Eur J Pharmacol (1986) 0.78
Effects of phosphodiesterase inhibition on skeletal muscle vasculature. Am J Cardiol (1989) 0.77
Evidence against serotonin as a vasoconstrictor neurotransmitter in the rabbit basilar artery. J Pharmacol Exp Ther (1986) 0.77
Antagonism of deslanoside-induced cardiotoxicity by combined nicotinic and muscarinic blockade of autonomic ganglia. J Pharmacol Exp Ther (1975) 0.77
Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin. J Clin Pharmacol (2000) 0.76
Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients. Pharm Res (1996) 0.76
Ventricular rhythm disorders and sudden cardiac death. Am J Med (1976) 0.76
Antagonism of ventricular arrhythmias induced by digitalis--a neural phenomenon. Eur J Pharmacol (1969) 0.75
The effect of digoxin on the binding of adriamycin to cat heart muscle. Br J Cancer (1977) 0.75
The effect of diphenidol on ouabain cardiotoxicity in the cat. Br J Pharmacol (1978) 0.75
Observation of nonlinear frequency-sweeping suppression with rf diffusion. Phys Rev Lett (2003) 0.75
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trial. Am J Clin Oncol (1998) 0.75
Digitalis: its place in therapy. J Clin Pharmacol (1985) 0.75
Idiopathic medical ascending aortopathy with associated valvular insufficiency. Surgical correction. N Y State J Med (1969) 0.75
Problems in new-drug development: therapeutic agents for ventricular arrhythmias. J Clin Pharmacol (1987) 0.75
Uptake and distribution of diphenylthiohydantion (DPTH). Eur J Pharmacol (1970) 0.75
The dissociation of the exaggerated prolactin and thyrotropin responses in seminiferous tubule failure following the administration of a double-pulse of thyrotropin-releasing hormone. J Endocrinol Invest (1983) 0.75
Jugular venous pulse recording in a patient without a tricuspid valve. Vasc Surg (1976) 0.75
The influence of heart rate on ouabain cardiotoxicity in cats with spinal cord transection. Eur J Pharmacol (1978) 0.75
Pseudotachycardia during 24-hour electrocardiographic monitoring. Angiology (1977) 0.75
Letter: Sleep and ventricular premature beats. Circulation (1974) 0.75
The clinical pharmacology of antiarrhythmic drugs. Part 1: Lidocaine and procainamide. Cardiovasc Nurs (1975) 0.75
Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual. N Y State J Med (1978) 0.75
Letter: Drugs for arrhythmias. Lancet (1975) 0.75
Proceedings: Nitroglycerin and nitroglycerin-phenylephrine-induced reduction in ischaemia during acute myocardial infarction in man. Br Heart J (1975) 0.75
Cardiomyopathy simulating myocardial infarction. Electrocardiographic and vectorcardiographic findings. N Y State J Med (1973) 0.75
The assessment of antidysrhythmic drugs. J Clin Pharmacol (1984) 0.75
The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Eur J Pharmacol (1979) 0.75
A comparison of actodigin and ouabain in cats. Arch Int Pharmacodyn Ther (1977) 0.75
Antiproton confinement in a Penning-Ioffe trap for antihydrogen. Phys Rev Lett (2007) 0.75
A comparison of the in vivo and in vitro actions of ouabain to produce cardiac arrhythmia. Arch Int Pharmacodyn Ther (1974) 0.75
Auscultation and phonocardiography. Adv Cardiopulm Dis (1966) 0.75
Blockade of tissue uptake of the antineoplastic agent, doxorubicin. J Pharmacol Exp Ther (1978) 0.75
Effects of actodigin on the heart. Clin Pharmacol Ther (1977) 0.75
Action of propranolol on atrioventricular conduction in the digitalis-intoxicated heart. Arch Int Pharmacodyn Ther (1971) 0.75
Protection of ischemic myocardium by nitroglycerin: experimental and clinical results. Circulation (1976) 0.75
The clinical pharmacology of antiarrhythmic drugs. Part II: Quinidine, propranolol, diphenylhydantoin, and bretylium. Cardiovasc Nurs (1975) 0.75
The influence of liver injury on the distribution of digitoxin in the rat. Arch Int Pharmacodyn Ther (1974) 0.75
Anticonvulsant properties of diphenylthiohydantoin. Arch Int Pharmacodyn Ther (1970) 0.75
The influence of cycle length on the effective and functional refractory period of the human AV node. Angiology (1988) 0.75
The influence of propranolol on ouabain uptake by the guinea pig heart. Eur J Pharmacol (1973) 0.75
Spinal excitatory and depressant effects of sodium diphenylthiohydantoinate. J Pharmacol Exp Ther (1971) 0.75
The influence of sympathetic nervous activity on the antiarrhythmic efficacy of diphenylhydantoin. Eur J Pharmacol (1970) 0.75
Unipolar subclavian and bipolar femoral catheter electrodes to pace heart: comparison of effectiveness. N Y State J Med (1972) 0.75
Neural basis for the genesis and control of digitalis arrhythmias. Cardiology (1976) 0.75
The influence of metiamide on ouabain cardiotoxicity. Eur J Pharmacol (1975) 0.75
The influence of N-isopropyl-p-nitro-phenylethanolamine (INPEA) on cardiotoxicity produced by digitoxin and digoxin. Arch Int Pharmacodyn Ther (1973) 0.75
Letter: The action of propranolol in man and animals. Circulation (1976) 0.75